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ABSTRACT Differences among individuals in susceptibility to infectious diseases can be modulated by host genetics. Much
of the research in this field has aimed to identify loci within the host genome that are associated with these differences. In
mice, A/J (AJ) and C57BL/6J (B6) mice show differential susceptibilities to various pathogens, including the intracellular
pathogen Francisella tularensis. Because macrophages are the main initial target during F. tularensis infection, we ex-
plored early interactions of macrophages from these two mouse strains with F. tularensis as well as the genetic factors un-
derlying these interactions. Our results indicate that bacterial interactions with bone marrow-derived macrophages
(BMDMs) during early stages of infection are different in the AJ and B6 strains. During these early stages, bacteria are
more numerous in B6 than in AJ macrophages and display differences in trafficking and early transcriptional response
within these macrophages. To determine the genetic basis for these differences, we infected BMDMs isolated from recom-
binant inbred (RI) mice derived from reciprocal crosses between AJ and B6, and we followed early bacterial counts within
these macrophages. Quantitative trait locus (QTL) analysis revealed a locus on chromosome 19 that is associated with early
differences in bacterial counts in AJ versus B6 macrophages. QTL analysis of published data that measured the differential
susceptibilities of the same RI mice to an in vivo challenge with F. tularensis confirmed the F. tularensis susceptibility QTL
on chromosome 19. Overall, our results show that early interactions of macrophages with F. tularensis are dependent on
the macrophage genetic background.
IMPORTANCE Francisella tularensis is a highly pathogenic bacterium with a very low infectious dose in humans. Some mecha-
nisms of bacterial virulence have been elucidated, but the host genetic factors that contribute to host resistance or susceptibility
are largely unknown. In this work, we have undertaken a genetic approach to assess what these factors are in mice. Analyzing
early interactions of macrophages with the bacteria as well as data on overall susceptibility to infection revealed a locus on chro-
mosome 19 that is associated with both phenotypes. In addition, our work revealed differences in the early macrophage response
between macrophages with different genetic backgrounds. Overall, this work suggests some intriguing links between in vitro
and in vivo infection models and should aid in further elucidating the genetic circuits behind the host response to Francisella
tularensis infection.
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Francisella tularensis is a highly pathogenic, facultative intracel-lular Gram-negative bacterium that infects a broad range of
hosts, including humans. In humans, even a very low dose of this
bacterium can cause tularemia, a severe and potentially lethal dis-
ease. F. tularensis can infect hosts through various routes, with the
intranasal route causing the most severe disease. Laboratory mice
have been extensively used as a model in which to explore various
aspects of this disease, including immunological response, bacte-
rial life cycle within the host, and vaccine development (1–4). To
date, the fully virulent SchuS4 strain and the attenuated live vac-
cine strain (LVS) of F. tularensis have been the most commonly
used mouse models of infection.
Although different mouse strains exhibit various suscepti-
bilities to F. tularensis infection (5, 6), the genetic basis for this
difference remains poorly understood. A locus on chromo-
some 1, designated Bcg, has been associated with differences in
susceptibility to F. tularensis (7). This locus harbors the Slc11a1
gene coding for natural-resistance-associated macrophage
protein 1 (NRAMP1), a divalent metal ion transporter. In
mice, two different alleles have been described for this gene that
control sensitivity to Salmonella enterica serovar Typhimu-
rium, Mycobacterium bovis, and Leishmania donovani (re-
viewed in reference 8) as well as to Francisella infection (7). In
Francisella, natural variation within this gene affects the mi-
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croenvironment of the phagosome and changes the ability of F.
tularensis to reside within the phagosome (9). Despite these
intriguing early reports, there have been no further studies on
the connection of this gene to F. tularensis resistance.
Tumor necrosis factor alpha (TNF-) and gamma interferon
(IFN-) are major cytokines involved in controlling tularemia in
vivo (2, 10, 11). Other genes, including those encoding Toll-like
receptor 2 (TLR2), AIM2, and cGAS (12–14), have been shown to
control tularemia. AIM2 and cGAS are important intracellular
sensors for Francisella DNA, whereas TLR2 detects lipopeptides
on the bacterial surface (15, 16). Recent studies have shown that
the bacteria can escape immune clearance in dendritic cells and
macrophages by actively suppressing the immune response in
these cells (17, 18). Together, the accumulating data suggest an
intricate relationship between the bacteria and host defense mech-
anisms.
Macrophages are considered the primary target site for Fran-
cisella infection and replication (19, 20). A recent study examining
the early interactions of F. tularensis with various cells after intra-
nasal challenge revealed that the majority of the bacteria were
associated with alveolar macrophages at the initiation of infection
(3). The life cycle of F. tularensis within macrophages involves
entry into the cells via opsonization-dependent or -independent
pathways. Opsonized bacteria interact with different receptors,
such as the C3 complement receptor (CR3), Fc receptor , or
scavenger receptor A (21, 22). Unopsonized bacteria enter the
cells via interaction with the mannose receptor (23, 24). After
internalization into the host cell, Francisella is trafficked through
the early and late phagosome but prevents fusion of the phago-
some with the lysosome and escapes into the cytosol, where it
replicates to high numbers before lysing the cell to initiate a new
round of infection (25). Whether natural genetic variation within
the host modulates any of these processes and thereby affects dis-
ease progression is unknown.
Two major strains of laboratory mice, A/J (AJ) and C57BL/6J
(B6), differ significantly in susceptibility to experimental tulare-
mia (6). In this study, we used AXB/BXA recombinant inbred (RI)
mice and their progenitors (AJ and B6 mice) to investigate the
relationship between macrophage genotype and response to F.
tularensis. AXB/BXA mice are derived from an initial reciprocal
cross of AJ (A) and C57BL/6J (B) mice followed by multiple (20)
rounds of inbreeding resulting in a homozygous and stable mosaic
of blocks of the parental alleles in their genomes (26). When chal-
lenged with F. tularensis, these mice showed a continuous pheno-
type, which is typical of a complex trait (5). Although the pheno-
type of these mice in response to F. tularensis infection was
described, the genetic basis underlying this differential suscepti-
bility was not discussed. RI mice were recently used to explore the
genetic factors that control the variable macrophage response to
stimulation with IFN- plus TNF- and the various susceptibili-
ties of macrophages to infection with the intracellular pathogen
Toxoplasma gondii (27).
Focusing on early bacterial association with macrophages and
using macrophages from RI mice, we have identified the specific
loci that are linked with differences in the early interactions of F.
tularensis with murine macrophages. Moreover, quantitative trait
locus (QTL) analysis of the published in vivo data suggests that the
same locus affecting early macrophage-F. tularensis interactions is
associated with differential susceptibilities to in vivo infection as
well.
RESULTS
Differences in susceptibility to F. tularensis infection in vivo are
dependent on host genetic background and are associated with
differences in dissemination. AJ and B6 mice have significantly
different bacterial burdens in the spleen at day 5 after F. tularensis
infection (5). In addition, mice from an RI library derived from
these strains display a continuous phenotype in response to F.
tularensis challenge (5). Initially, we confirmed major survival dif-
ferences between the AJ (sensitive) and B6 (resistant) mouse
strains after intranasal challenge with F. tularensis LVS (Fig. 1A).
The median times to death after intranasal challenge with
250 CFU were 8 and 12 days for AJ and B6 mice, respectively (P
0.002 [log rank test]). In addition to survival, we assessed bacterial
burden in several major organs. Bacterial burdens in the lung on
day 6 after infection did not differ significantly in the two mouse
strains (Fig. 1B); this result suggested similar abilities of F. tular-
ensis to colonize the lungs—the initial site for colonization—in
the two strains. In contrast, bacterial numbers in the spleen and
liver differed significantly in AJ and B6 mice. In both cases, bacte-
rial counts on day 6 after infection were significantly lower in B6
mice than in AJ animals (Fig. 1C and D). Taken together, these
results confirm the differences in susceptibility between these
strains in terms of both survival and bacterial burden in major
organs.
Differences in bacterial counts during in vitro infection are
manifested mainly at early time points. As macrophages are the
main initial target in F. tularensis infection, we tested whether the
in vivo differences in susceptibility between AJ and B6 mice are
also evident during in vitro infection in macrophages. For this
purpose, we used a well-established, synchronized model of infec-
tion, strictly measuring only intracellular bacteria (for details, see
reference 28 and Materials and Methods). Testing bone marrow-
derived macrophages (BMDMs), we found that the bacterial
growth index (the ratio between bacterial counts at 24 h and 2 h)
was significantly higher for AJ than for B6 BMDMs (Fig. 2A). The
differences in bacterial counts were evident at the initial stage of
infection (2 h after infection) (Fig. 2B), whereas at the later time
point (24 h) there was no significant difference between bacterial
counts in BMDMs from the two sources (Fig. 2C). The similar
levels of expression of major macrophage markers such as CD11b
and F4/80 in BMDMs from these two mouse strains suggested
similar maturation states (Fig. 2D).
To assess the relevance of these results to infection with a fully
virulent strain, we tested F. tularensis SchuS4 bacterial prolifera-
tion in these BMDMs. Similarly to the LVS, SchuS4 had a higher
bacterial growth index in AJ macrophages than in B6 cells, with
significantly different bacterial counts at 2 h but not at 24 h after
infection (see Fig. S1 in the supplemental material). Finally, in an
ex vivo experiment, a similar trend was observed in resting un-
stimulated peritoneal macrophages (results not shown). Overall,
these data indicate that F. tularensis is initially better at entering B6
macrophages but, once inside the cells, grows better in AJ macro-
phages.
Differences in bacterial growth are dependent on early
bacterium-macrophage interactions andon themacrophage ac-
tivation state. The differences between the 2 cell lines 2 h after F.
tularensis infection prompted us to ask whether there is a differ-
ence in bacterial uptake. Confocal microscopy of BMDMs at the
initiation of F. tularensis infection revealed greater bacterial asso-
Fink et al.
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ciation with B6 than with AJ BMDMs as well as significant differ-
ences in the percentages of cells infected (Fig. 3A and B). These
results are in line with our observations at 2 h after infection and
suggest that, at early time points during infection, bacterial num-
bers are higher in B6 than in AJ macrophages. Comparison of
these data with those on the uptake of S. enterica serovar Typhi-
murium by these macrophages suggested no significant difference
in the percentages of macrophages infected with S. enterica as well
as no difference in bacterial counts per cell (Fig. 3C and D).
Macrophage activation by various pathways can strongly influ-
ence the macrophage phenotype. We tested whether the macro-
phage activation state affects the differences observed in bacterial
uptake or growth. Activation of the cells with lipopolysaccharide
(LPS) from Escherichia coli prior to infection abolished the differ-
ential bacterial growth indices of the strains (see Fig. S2 in the
supplemental material). LPS treatment resulted in higher bacterial
counts at both early and late time points, with similar magnitudes
for the two cell lines. Thus, LPS activation resulted in similar levels
of bacterial growth in the two BMDM strains.
Insights into the specificpathways thatmodulatedifferential
susceptibilities to F. tularensis in AJ and B6 BMDMs. We as-
sessed whether the observed differences in bacterial counts are
associated with different transcriptional responses in B6 and AJ
BMDMs. As we were interested in early time points, we infected
these 2 cell lines with F. tularensis in vitro and used RNA sequenc-
ing (RNA-seq) to profile their transcriptional responses in the
resting state and at 2, 4, and 10 h after infection. We further ana-
lyzed our data with gene-set enrichment analysis (GSEA) to ob-
tain a detailed profile of the specific pathways that are either sup-
pressed or induced during early infection in macrophages. Based
on an analysis of more than 900 cellular pathways and networks,
our results suggest that the overall responses of the 2 cell lines are
highly similar (Fig. 4A). The response consists mainly of a strong
nuclear factor B (NFB) response 2 h after infection that turns
into an interferon response at 10 h. At the latter time point, IFN
type I and type II pathways are significantly upregulated (Table 1).
Although the overall profiles are highly similar, a closer look at the
exact genes that are upregulated within these pathways reveals
significant differences between the strains. Overall, at 2 h after
infection, expression of many proinflammatory genes (such as
those encoding TNF, CXCL1, CXCL2, and interleukin-1 [IL-
1]) is induced to a higher degree in B6 than in AJ macrophages.
The picture is similar for various genes that constitute the inter-
feron response (e.g., those encoding interferon regulatory factor 1
[IRF1], IFIT1 to IFIT3, ISG15, and MX1), which are significantly
more upregulated in B6 than in AJ macrophages (Fig. 4B and C).
Furthermore, compared to those in uninfected cells (i.e., at time
zero), TNF gene transcript levels at 4 h and 10 h after infection
seem to remain high for B6 but not for AJ. The exact downstream
effects of these differential responses remain unknown, as the lev-
els of primary proinflammatory cytokines such as TNF-, inter-
leukin 6 (IL-6), IL-1, and IFN- are very low in the supernatants
of both cell lines, even after 24 h (results not shown).
In addition, we investigated the early trafficking of the bacteria
within the macrophages. Early trafficking and movement into the
cytosol can have a significant effect on the intracellular fate of
bacteria and thus on the infection process (29). We looked at
bacterial colocalization with the early endosomal marker EEA1 at
FIG 1 Differential susceptibilities of AJ and B6 mice to F. tularensis LVS infection. (A) Mice (n 5) of either the AJ or the B6 strain were infected intranasally
with LVS (250 CFU), and mortality in response to infection was followed for up to 25 days. Both time to death and percent mortality differed in the two strains.
(B to D) AJ or B6 mice were infected intranasally with 250 bacterial CFU. Bacterial counts in lungs (B), liver (C), and spleen (D) were evaluated on day 6 after
infection. While no statistically significant difference was found at the primary site of infection (lungs, P 0.075), differences were statistically significant in liver
(P 0.0167) and spleen (P 0.001). Statistical analysis was done with the Mann-Whitney nonparametric test. NS, not significant.
Early Macrophage Interaction with F. tularensis
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the initiation of infection and after 1 h and at colocalization with
the LAMP1 late endosomal marker after 2 h (see Fig. S3 in the
supplemental material). While there was no significant difference
in the percentages of bacteria colocalized with EEA1, after 2 h a
larger percentage of bacteria were associated with LAMP1 in B6
than in AJ macrophages. Taken together, our results suggest dif-
ferential trafficking of bacteria in these two lines (Fig. 4D and E).
Finally, we investigated whether there are differences in cyto-
toxicity between these 2 cell lines in response to F. tularensis infec-
tion. Cytotoxicity in response to Francisella infection is dependent
on AIM2 inflammasome activation (30). In the resting state, both
cell lines exhibited very low cytotoxicity; at a high multiplicity of
infection (MOI), some cytotoxicity was observed, but its levels
were not different in the two strains (Fig. 4F).
In vitro F. tularensis infection of BMDMs derived from RI
mice. Once we implemented an in vitro infection system that
showed differences in bacterial numbers within macrophages
from B6 and AJ mice at early time points, we monitored bacterial
counts 2 h after infection of BMDMs from 26 RI mice with F.
tularensis at an MOI of 50. Our results showed a gradual pheno-
type across the library that is typical for a complex multi-trait
phenotype (Fig. 5). While BMDMs derived from AJ mice had the
fewest bacteria per cell, B6 macrophages exhibited an intermedi-
ate phenotype in which several other RI strains had higher num-
bers of bacteria.
QTL analysis reveals a locus on chromosome 19 that is asso-
ciated with bacterial numbers at early time points after infec-
tion.The differences in F. tularensis association with macrophages
at the initiation of infection as well as the differences in early
trafficking and early transcriptional response prompted us to ex-
plore the genetic loci associated with these phenotypes. As all these
phenotypes represent changes occurring early in infection, we
performed QTL analysis of bacterial numbers in RI BMDMs 2 h
after infection. Our analysis suggested that bacterial counts at 2 h
corresponded to a locus on chromosome 19 (22.410 Mb; Fig. 6A).
Previous studies showed that bacterial numbers measured on
day 5 after infection in the spleen of mice from the RI library show
a typical gradual phenotype (5). To gain insight into the genetic
loci behind this phenotype, we performed QTL analysis on this
data set. Our analysis suggested three different loci that are asso-
ciated with the in vivo phenotype located on chromosomes 1
(79.900 Mb), 2 (27.662 Mb), and 19 (21.572 Mb), respectively
(Fig. 6B). To test whether the in vivo loci interact with one an-
other, we fixed the genotypes in a specific locus and measured the
effect on the other loci. A significant increase in the logarithm-of-
odds (LOD) score for a specific QTL suggests that it interacts with
the QTL that is fixed. We showed that the QTLs on chromosomes
1 and 2 interact with each other, while the QTL on chromosome
19 was not affected (Fig. 6C, D, and E).
DISCUSSION
Susceptibility to bacterial infection is often a complex trait. Thus,
the interaction of multiple genes is likely to determine the out-
come of infection (for a review, see reference 31). Just like indi-
viduals within a community, different inbred mouse strains show
different levels of susceptibility to various pathogens (5, 26, 32).
FIG 2 Differential growth of F. tularensis LVS in AJ and B6 BMDMs. (A) Bacterial growth was assessed in an in vitro infection assay. Intracellular bacterial counts
were measured 2 h and 24 h after infection at an MOI of 50. The bacterial growth index represents the ratio between bacterial counts at 24 h and 2 h (CFU at
24 h/CFU at 2 h; P 0.002). (B) Initial intracellular bacterial counts 2 h after infection (P 0.023). (C) Final intracellular bacterial counts 24 h after infection
(P 0.57). Each data point represents the average of results from a single experiment; statistical analysis was done with the unpaired t test. (D) FACS analysis of
AJ and B6 BMDMs. BMDMs (day 8) were stained for major macrophage markers CD11c and F4/80. The overall staining patterns were similar for the 2 cell
populations.
Fink et al.
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Although early work identified differences in susceptibility to F.
tularensis infection among several commonly used mouse strains,
the genetic variation underlying these differences remains un-
known.
Previous studies showed that AJ and B6 mice differ in suscep-
tibility to in vivo infection with F. tularensis. Because of the com-
plexity of in vivo challenge and the multitude of possible biochem-
ical networks and molecular interactions that may influence
disease outcome, we decided to explore this area using a simplified
and systematic approach: in vitro infection of BMDMs with F.
tularensis. We hypothesized that because macrophages are a pri-
mary target for F. tularensis infection, especially in its early stages
(3), differences in susceptibility to in vivo infection in different
mouse strains might be recapitulated in vitro. Hence, we further
hypothesized that a more confined in vitro challenge would be
more useful to define the underlying genetics.
Our results clearly show differences in F. tularensis LVS growth
within these macrophages. Bacterial growth is faster in AJ (suscep-
tible strain) than in B6 (resistant strain) macrophages. Results
were similar for fully virulent strain SchuS4. This difference in
growth reflects differences between bacterial counts in the 2 cell
lines at early time points. Abolishing the differences in early stages
of infection by activating cells with LPS before adding F. tularensis
resulted in similar levels of bacterial growth in the 2 cell lines. This
result suggests that the initial resting state of the macrophages is a
crucial factor in studies of these differences and is of broader sig-
nificance in experiments performed with prestimulated macro-
phages (e.g., thioglycolate-elicited peritoneal macrophages). In
these cases, results should preferably be confirmed by comple-
mentary experiments performed with resting unstimulated mac-
rophages.
In addition to differences in bacterial growth and counts at
early time points during infection, our results show differences
between B6 and AJ macrophages in bacterial uptake (i.e., early
association) and trafficking as well as in transcriptional response
during in vitro infection. Using QTL analysis of early bacterial
counts within macrophages from a library of RI mice harboring
mosaic genomes of AJ and B6, we defined a QTL on chromosome
19 that is associated with this phenotype. Furthermore, analysis of
available data on in vivo infection revealed a QTL on chromosome
FIG 3 Differences in F. tularensis LVS association with AJ and B6 BMDMs at the initiation of infection. (A) Bacteria were added to BMDMs and spun down to
allow a synchronized starting point for infection. Immediately after the spin, cells with bacteria were fixed with paraformaldehyde. BMDMs were stained with
actin phalloidin (green); nuclei were stained with DAPI (blue); and bacteria were stained with antibodies to LPS (red). Images are from a representative
experiment. (B) Average bacterial counts per cell and percentages of cells infected were found to be markedly lower for AJ than for B6 macrophages. Analysis was
done on 150 to 250 cells per experiment. (C and D) BMDMs were infected with S. Typhimurium (SL1344) in a manner similar to that described for panels A and
B. Neither bacterial counts per cell (P 0.067) nor percentages of macrophages infected (P 0.72) differed significantly between the two strains. For both F.
tularensis and S. Typhimurium, the results shown represent three independent experiments. Statistical analysis was done with single-factor analysis of variance
(ANOVA).
Early Macrophage Interaction with F. tularensis
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19 that overlaps the in vitro QTL as well as two other QTLs on
chromosomes 1 and 2.
The finding of a QTL on chromosome 1 that is associated with
differential levels of susceptibility to F. tularensis infection is in line
with published data. This locus (termed the Bcg locus) harbors the
Slc11a1 gene encoding NRAMP1, which controls susceptibility to
several intracellular bacteria, including F. tularensis (reviewed in ref-
erence 8). Sequenced genomes of B6 and AJ (from the Wellcome
Trust Sanger database) show that AJ carries the Asp-169-Gly substi-
tution, which was previously reported to confer sensitivity to F. tula-
rensis infection (7), as well as a single nucleotide polymorphism
(SNP) at the 3= untranscribed region (UTR) of the Slc11a1 gene. Al-
though the variation at position 169 is known to affect susceptibility
to F. tularensis infection, the SNP at the 3= UTR has not been charac-
terized. Our results not only confirm that natural variation in the
NRAMP1 gene at the Bcg locus contributes to F. tularensis suscepti-
bility but also suggest that two more previously unknown QTLs are
present on chromosomes 2 and 19. The QTLs at the Bcg locus on
chromosome 1 and the previously unpublished QTL on chromo-
some 2 seem to be interacting with each other; this interaction sug-
gests that the genetic elements important in determining susceptibil-
ity to F. tularensis infection on these chromosomes are coregulated.
The observation that the QTL on chromosome 19 found by in vivo
analysis overlaps with that found by in vitro analysis suggests that a
regulatory element may be shared in in vitro macrophage infection
and in vivo intranasal infection.
FIG 4 Analysis of differences between AJ and B6 BMDMs in transcriptional response, bacterial trafficking, and cytotoxicity throughout infection with F.
tularensis LVS. (A) BMDMs were infected, and early macrophage transcriptional response was monitored. RNA-seq data from 2, 4, and 10 h after infection were
analyzed on a GSEA platform. More than 900 pathways were scored for upregulation (red) or downregulation (blue) in comparison to resting, untreated
BMDMs. The overall transcriptional responses to in vitro infection were remarkably similar for the 2 cell lines. (B and C) Selected genes from the top 10 most
upregulated immune-related pathways at 2 h (B) and 10 h (C). Shown are all genes whose expression levels were at least 1.5-fold different between AJ and B6
BMDMs. (D and E) After BMDM infection, LVS colocalization with the early endosomal marker EEA1 was assessed at 10 and 60 min (D) and colocalization with
the late endosomal marker LAMP1 was assessed at 2 h (E). While no difference was observed for EEA1, a significant difference was documented for LAMP1, with
more colocalization in the B6 strain than in the AJ strain. The results shown represent three independent experiments, with 100 to 200 cells analyzed at each time
point. (F) BMDM cytotoxicity in response to LVS infection was assessed 24 h after infection. Levels of cytotoxicity did not differ significantly between AJ and B6
BMDMs. Statistical analysis was done with one-way ANOVA (P 0.39).
TABLE 1 Upregulation of NFB and IFN type I and II pathways in response to F. tularensis infectiona
Mouse
strain
and cell
type
2 h postinfection 10 h postinfection
NFB canonical pathway NFB atypical pathway Interferon signaling Interferon / Interferon 
NES Rank P val NES Rank P val NES Rank P val NES Rank P val NES Rank P val
B6 Mø 2.075 6 0.001 2.023 10 0.002 2.42 1 0.001 2.34 2 0.001 2.24 3 0.001
AJ Mø 2.049 1 0.001 1.97 6 0.002 2.12 2 0.001 2.08 3 0.001 2.07 4 0.001
a NES, normalized enrichment score; Mø, macrophage; P val, P value.
Fink et al.
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Although the chromosome 19 QTL is shared by the in vitro
and in vivo infection models, it remains a daunting task to
identify the exact genes within this region that control these
phenotypic differences. The major obstacle is the fact that sus-
ceptibility to F. tularensis infection is a highly complex trait. As
such, it involves the concerted interaction of many genes, with
each individual gene making only a small contribution to the
overall phenotype. This point is nicely illustrated by our obser-
vations in the in vivo infection model showing that all the QTLs
found had similar LOD scores and that no QTL seemed to be
more prominent than or dominant over the others. In addi-
tion, it has been suggested that the range of the genetic loci
obtained from QTL analysis can cover 10 to 20 cM (33), a
value range that in this case corresponds to ~20 Mb and sug-
gests many dozens of candidate genes. Often, the situation is
made even more complicated by the interaction of several
smaller QTLs within a larger QTL. In short, the situation is
highly complex, potentially including the interaction of several
individual genes (perhaps within the QTL) to produce the ob-
served LOD signal. An examination of the literature indicates
that few papers have described the exact gene within a QTL that
is contributing to a given phenotype and that the great majority
of QTL analyses have defined only the genetic loci associated
with a specific phenotype (34, 35). Nevertheless, it is intriguing
that early events during macrophage infection and bacterial
counts during in vivo infection are associated with the same
genetic locus. Further studies must better define the relation-
ship between the in vitro and in vivo infection models and must
determine whether early bacterium-macrophage associations
in vivo can influence overall disease outcome.
Recent work has demonstrated that early interactions of F. tu-
larensis with different macrophage surface molecules can affect
the intracellular fate of the bacteria. Geier and Celli showed that
association of complement-opsonized bacteria with CR3 prevents
phagosome maturation and restricts phagosomal escape whereas
association of IgG-opsonized bacteria with the Fc receptor
enhances superoxide production and results in decreased intracel-
lular proliferation (21). Furthermore, Dai et al. showed that inter-
action with CR3 inhibited TLR2 activation in an MKP1-
dependent manner (29). Our work supports the idea that early
events during in vitro bacterial infection influence the outcome of
the infection. Higher bacterial counts at the initiation of infection
are correlated with an altered transcriptional response and altered
trafficking within macrophages. In addition, we propose for the
first time that these kinetics of bacterial uptake and proliferation
within the macrophage are influenced by the genetic background
of the macrophages.
Enhanced transcription of several genes within the NFB and
IFN pathways in B6 BMDMs in response to F. tularensis infection
is also intriguing. Among the genes that are upregulated in B6
macrophages in response to F. tularensis is that encoding IFN
regulatory factor 1 (Irf1). This transcription factor was recently
shown to be crucial for the activation of guanylate-binding pro-
teins, ultimately promoting the killing of intracellular bacteria by
these proteins (36). In addition, the fact that high TNF gene tran-
script levels were sustained in B6 but not in AJ macrophages in
response to F. tularensis infection suggests a better response to F.
tularensis infection in B6 BMDMs. Live F. tularensis can actively
suppress TNF gene induction in a variety of human and mouse
cells (37), whereas a mutant that is incapable of escaping the
phagosome triggers constant activation and secretion of TNF-.
Similarly, active suppression of IFN- by Francisella results in im-
proved bacterial survival inside mononuclear phagocytes (38).
Taken together, these studies support the idea that the increased
NFB and IFN signaling by B6 is associated with the slower bac-
terial growth rate in these macrophages than in AJ macrophages.
Further studies will explore whether this differential induction of
major regulatory genes such as the Irf1 gene and the Tnf gene
occurs in vivo and what consequences of such differences are pos-
sible in vivo.
In summary, we have characterized some early interactions of
macrophages with F. tularensis and have shown that these inter-
actions are dependent on the host genetic background. In addi-
tion, we have identified novel QTLs associated with in vitro and in
vivo susceptibility to F. tularensis infection. Our observation of the
association of a specific genetic locus on chromosome 19 with
both in vitro and in vivo infection models should facilitate further
elucidation of the genetic circuits underlying differential suscep-
tibilities to F. tularensis infection.
FIG 5 Intracellular bacterial numbers in the AJxB6 RI BMDM library 2 h after infection with F. tularensis LVS (MOI, 50). Strict measurement of only
intracellular bacteria was performed (see Materials and Methods). Means and standard deviations are shown for each strain.
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MATERIALS AND METHODS
Ethics statement. Animal studies were carried out in strict accordance
with the guidelines in the Guide for the Care and Use of Laboratory Ani-
mals (39). The protocol was approved by the Harvard Medical Area
Standing Committee on Animals (protocol 04723) and the Massachusetts
Institute of Technology Committee on Animal Care (assurance number A
3125-01; protocol number CAC 0611-063-14).
Bacterial strains and handling. F. tularensis LVS (kindly provided by
Karen Elkins, U.S. Food and Drug Administration, Bethesda, MD) and
fully virulent F. tularensis strain SchuS4 (provided by the Tufts New Eng-
land Regional Biosafety Laboratory, Grafton, MA) were grown on cys-
teine heart agar plates supplemented with 1% hemoglobin (CHA) for 48
to 72 h at 37°C in 5% CO2. For liquid medium cultures, bacteria were
grown in tryptic soy broth (Difco, Detroit, MI) supplemented with ferric
pyrophosphate and L-cysteine. Salmonella enterica serovar Typhimurium
(SL1344) was grown on LB agar or broth supplemented with streptomy-
cin sulfate (200 g/ml).
In vivo experiments. Male B6 or AJ specific-pathogen-free mice
(Jackson Laboratory, Bar Harbor, ME) (6 to 8 weeks old) were housed in
a biosafety level 2 (BL2) animal facility at Harvard Medical School. The
mice, slightly anesthetized with isoflurane (Baxter, Deerfield, IL), were
infected intranasally with 250 CFU of F. tularensis LVS in sterile
phosphate-buffered saline (PBS) (50l) and followed for survival or bac-
terial burden.
To determine bacterial burden, mice were euthanized and specific
tissues (lung, spleen, and liver) were collected 6 days after infection. Or-
gans were weighed, hand-mashed, and homogenized with a Stomacher
80-paddle action blender (Seward, Port Saint Lucie, FL). Serial 10-fold
dilutions were prepared with sterile PBS supplemented with 2% fetal bo-
vine serum (FBS). A 10-l volume of each dilution was plated onto CHA
and incubated at 37°C in 5% CO2 until colonies became visible (~48 h).
Data were expressed as total CFU per organ.
Preparation of BMDMs and in vitro infection. Femurs of mice were
collected and sterilized with 70% ethanol. Bone marrow was flushed with
PBS, filtered, and spun down. The cell pellet was resuspended in supple-
mented BMDM growth medium—i.e., Dulbecco’s modified Eagle’s me-
dium (DMEM) containing D-glucose (4.5 mg/liter), L-glutamine (4 mM),
and sodium pyruvate (110 mg/liter) (Invitrogen, Carlsbad, CA) and sup-
plemented with 10% heat-inactivated, low-endotoxin-unit FBS (Invitro-
gen) and 20% cell line L929-conditioned DMEM with nonessential amino
acids. The cells from each femur were plated in 4 deep petri dishes, and the
plates were incubated at 37°C in 5% CO2. After 4 days, additional supple-
mented BMDM growth medium was added to petri dishes. Cells either
were frozen on day 8 (FBS with 10% dimethyl sulfoxide [DMSO]) at
A B
C
2.0
1.5
1.0
0.5
0.0
3.0
2.5
LO
D
Map position (cM)
10 3020 40 500
Chromosome
1 2 19
2.0
3.0
1.0
0.0
5.0
4.0
LO
D
1.0
1.5
0.5
0.0
2.0
2.0
3.0
1.0
0.0
5.0
4.0
2.5
1 2 19 1 2 19 1 2 1912
Chromosome
D E
2.0
1.5
1.0
0.5
0.0
3.0
2.5
Chr 19
FIG 6 QTL analysis of in vitro and in vivo infection with F. tularensis LVS. (A) QTL analysis of bacterial counts 2 h after infection (see Fig. 5) revealed a locus
on chromosome 19 (22.410 Mb) that was associated with this phenotype. (B) QTL analysis of LVS counts in spleen on day 5 after infection (see reference 5)
showed three major loci on chromosomes 1 (79.900 Mb), 2 (27.662 Mb), and 19 (21.572 Mb), respectively. QTL positions on chromosome 19 are adjacent and
overlapping. (C to E) In vivo QTL analysis showed that genetic loci on chromosomes 1 and 2 interact with each other, whereas the QTL on chromosome 19 does
not interact with these loci. Fixing the genotype at the QTLs on chromosome 1 (C) and chromosome 2 (D) enhanced the signal for the QTLs on chromosomes
2 and 1, respectively. In contrast, fixing the genotype at the QTL on chromosome 19 (E) did not affect the QTLs on chromosomes 1 and 2.
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180°C and kept for later use or were used directly for in vitro infection as
described below.
On day 8, cells were detached from plates, counted, and plated (onto a
24-well plate at a density of 105 cells per well) in the presence of 10%
L929-conditioned DMEM. The following day (day 9), bacteria (F. tular-
ensis LVS or SchuS4) were streaked from a plate containing a 2- to 3-day-
old culture and grown to an optical density (OD) of 0.3 (  620 nm).
Bacteria were spun and washed with sterile PBS (Invitrogen) and then
resuspended in BMDM at an MOI of 50 or 100. Immediately before in-
fection, cells were washed twice with PBS and the medium containing the
bacteria was added. Cells were spun at 300  g for 7 min to allow a
synchronized infection starting point (t 0). BMDMs and bacteria were
incubated for 45 min and then washed twice, after which medium con-
taining gentamicin (20 g/ml) was added for 1 h. Cells were washed and
either lysed with 1% saponin–PBS (t  2 h) or supplemented with new
medium and grown for an additional 22 h (t  24 h) and lysed as de-
scribed above. Bacteria in saponin were serially diluted in PBS and plated
onto CHA. Growth was recorded 48 to 72 h later. This procedure is based
on standard in vitro procedures described elsewhere (28, 40). Surplus cells
that were not used for in vitro infection were frozen on day 8 (FBS with
10% DMSO) at 180°C and kept for later use. BMDMs from RI mice
were obtained as described elsewhere (41).
FACSanalysis.On day 8, BMDMs from AJ and B6 mice were detached
from the plate with ice-cold PBS, spun down, and transferred to a round-
bottom 96-well plate at a density of 2.5 105 to 5 105 cells per well. Cells
were spun down at 500  g, and PBS was replaced with 90 l of
fluorescence-activated cell sorter (FACS) buffer (10 mM EDTA, 15 mM
sodium azide, 1% bovine serum albumin [BSA], PBS; pH 7.35) with a
1:100 concentration of Fc-blocking antibody (CD16/32; BioLegend).
Cells were incubated on ice for 30 min and then washed and incubated
with antibodies to CD11b (BioLegend) and F4/80 (eBioscience) or isotype
controls. After further incubation for 30 min, cells were washed and ana-
lyzed on a MACSQuant Analyzer (Miltenyi Biotec, San Diego, CA). Data
were analyzed with FlowJo software (Ashland, OR).
Confocal microscopy. On day 6 or 7, BMDMs were counted and
plated onto a 24-well plate containing a 1.5-thickness coverslip (Thermo
Scientific) at a low density (5 104 cells per well). The following day, cells
were washed and bacteria (F. tularensis LVS or S. Typhimurium) were
added at an MOI of 50. Cells were centrifuged at 300 g for 7 min to allow
rapid bacterial adherence to cells, and slides were fixed (with 2.5% para-
formaldehyde for 15 to 30 min and subsequent replacement with PBS) at
0, 10, 60, or 120 min after infection. Cells were permeabilized and blocked
in PBS containing Triton X-100 (0.1%), horse serum (5%), and BSA
(0.5%) for 30 min. Washing of cells with PBS was followed by the addition
of the specific antibodies described for each experiment—i.e., antibodies
to F. tularensis LPS (Abcam), S. Typhimurium LPS, EEA1, and LAMP1
(Santa Cruz). Incubation with primary antibody was followed by incuba-
tion with secondary antibody (Alexa Fluor; Invitrogen) and the specific
fluorophores for 30 min. DAPI (4=,6-diamidino-2-phenylindole) (1 g/
ml) was added for 15 min. For actin staining, Alexa Fluor phalloidin
(4 U/ml) was added for 20 min. Coverslips were washed, dried, and placed
on the slide with 15l of mounting medium. Pictures were obtained with
an Olympus FV1000 confocal microscope and were analyzed with Fiji
software (42).
RNA sequencing (RNA-seq) and bioinformatic analysis. Frozen
BMDMs were thawed and plated with supplemented DMEM as described
above. On day 12, cells were counted and plated onto a 12-well plate at a
density of 3 106 per well. The next day, cells were washed and bacteria
(LVS) were added at an MOI of 100. Total RNA was extracted (RNeasy;
Qiagen) at time zero (no bacteria) and at 2, 4, and 10 h after infection and
was immediately stored at80°C. Illumina library preparation, sequenc-
ing, and data processing were done as previously described (43). In brief,
mRNA was purified from total RNA by poly(A)-tail enrichment (Dyna-
beads mRNA purification kit; Invitrogen), fragmented into 200 to 400 bp,
and reverse transcribed into cDNA before Illumina sequencing adapters
were added to each end. Libraries were barcoded, multiplexed into four
samples per sequencing lane in the Illumina HiSeq 2000 system, and se-
quenced from both ends; this process resulted in 40-bp reads after the bar
codes were discarded.
The RNA-seq reads were mapped to a synthetic mouse genome
(mm10) in which all the single polymorphic nucleotides (as annotated by
Wellcome Trust Sanger Institute sequencing; ftp://ftp-mouse.sanger-
.ac.uk/current_snps/) between AJ and B6 were masked with Bowtie2
(2.2.3) (44) and TopHat (v2.0.4) (45). Gene expression levels were then
estimated as fragments per kilobase of exon per million fragments
mapped (FPKM) in CuffLinks (v2.2.0) (46). At each time point, gene fold
changes from baseline (defined as RNA levels from resting, uninfected,
and unstimulated cells) were determined for both AJ and B6 BMDMs. The
ranked lists of the fold changes (.rnk files) were analyzed by GSEA to
determine which cellular pathways were upregulated, downregulated, or
unchanged. With this platform, a total of 917 pathways were analyzed and
scored. For samples from 2 and 10 h after infection, specific genes from
each of the top 10 upregulated immunological pathways were combined
and analyzed. Sorting and visualization of the data was done using SPIN
(47). Genes with a 1.5-fold or greater difference between the AJ and B6
results were plotted.
QTL mapping. The genomic loci that regulate bacterial burden in
AXB/BXA BMDMs were determined as previously described (43). In
brief, we used 934 AXB/BXA genetic informative markers obtained from
http://www.genenetwork.org to perform a genome-wide scan in R/qtl
(48). The significance of QTL LOD scores was assessed with 1,000 permu-
tations of the phenotype data, as has been described (49), and the corre-
sponding P values were reported. QTL significance was reported at a
genome-wide threshold corresponding to P values of0.05.
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